Psoriasis and obesity are both characterized by overexpression of key proinflammatory cytokines, hsCRP and IL-6, which have been accepted as classical markers of CVD risk and are therefore valuable markers for the assessment of the cardiovascular status of patients with PS. Here, IL6 is linked to Obesity.